Use of Pharmacogenomics in Transplant Patients

Speaker: Nathan Lamb, PharmD, BCPPS
Pharmacogenomics Coordinator
Ann & Robert H. Lurie Children’s Hospital of Chicago

A Knowledge-Based Activity

ACPE UAN: 0016-9999-24-069-L01-P, 0.75 contact hours (0.075 CEUs)
CNE Credit: 0.75 hours CNE

Learning Objectives:

• Review concepts and nomenclature of pharmacogenomics
• Summarize clinical evidence supporting CYP3A5 genotype guided tacrolimus dosing in transplant patients
• Outline relevant guidelines regarding additional medications often utilized in transplant patients

Disclosures:

Dr. Nathan Lamb has no relevant financial conflicts of interest to disclose in relation to this activity.